Search results
Results from the WOW.Com Content Network
Influencers such as Peter Attia, MD are currently taking the drug “off label” for its anti-aging potential. Attia said that rapamycin, “hands down [is] the most important and exciting and ...
Peter Attia (born March 19, 1973) [1] is a Canadian-American author, physician, and researcher known for his work in longevity medicine. Early life and education
Sirolimus, also known as rapamycin and sold under the brand name Rapamune among others, is a macrolide compound that is used to coat coronary stents, prevent organ transplant rejection, treat a rare lung disease called lymphangioleiomyomatosis, and treat perivascular epithelioid cell tumour (PEComa).
Montgomery received his general surgical training at Johns Hopkins Hospital from 1987 to 1995. [citation needed] He was a co-resident with Peter Attia. [4]During his residency, he took time out to complete his D.Phil in Transplantation Biology at the University of Oxford, graduating in 1993.
AOL latest headlines, entertainment, sports, articles for business, health and world news.
Get AOL Mail for FREE! Manage your email like never before with travel, photo & document views. Personalize your inbox with themes & tabs. You've Got Mail!
Image credits: Bored Panda #2 Dave Grohl Fathered A Baby Girl Outside Of His Marriage. Lead singer of the Foo Fighters Dave Grohl isn’t trying to hide his truth. Back in September, the musician ...
The mammalian target of rapamycin (mTOR), [5] also referred to as the mechanistic target of rapamycin, and sometimes called FK506-binding protein 12-rapamycin-associated protein 1 (FRAP1), is a kinase that in humans is encoded by the MTOR gene. [6] [7] [8] mTOR is a member of the phosphatidylinositol 3-kinase-related kinase family of protein ...